QurAlis Hires Key Regulatory Affairs, Clinical Operations, and Global Supply Chain Management Experts to Support Strategic Objectives
- Tuesday, February 8, 2022, 8:02
- Finance
- Add a comment
CAMBRIDGE, Mass., Feb. 8, 2022 /PRNewswire/ — QurAlis Corporation, a biotech company developing breakthrough precision medicines for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases with genetically validated targets, today announced an expansion of its leadership…
About the Author
adminasapcorp has written 41558 stories on this site.